Industry reports
Editor highlights

Biopharmaceutical Industry in Switzerland: Market Research Reports, Statistics and Analysis

You might be interested in: biosimilar, protein, bioprocessing, more »

» View Public Reports

9 reports

Biopharmaceutical Sector Statistics in The United States, Switzerland and The Czech Republic

  • Industry report
  • April 2012
  • 39 pages

... Viral vector gene therapy, viral vaccine applications) slide 27 strain development and cell banking fermentation and recovery development purification and refold development analytical development ...

Bioprocessing Sector in The United States and Switzerland

  • Industry report
  • June 2013
  • 25 pages

... For including temperature as factor are to increase the yield of active recombinant protein through the increase of solubility [23-25], more efficient folding through slower protein expression [26,27], less ...

Biopharmaceutical Sector in Switzerland, The United States and The United Kingdom

  • Industry report
  • October 2011
  • 8 pages

... European mab biosimilar guideline overcome the unique manufacturing challenges facing the development of novel therapies such as bi-specifics, antibody fragments, combination antibodies and adcs find novel ...

Biopharmaceutical Business in Germany, The United States and Switzerland

  • Industry report
  • June 2011
  • 8 pages

... Ingelheim has brought 17 molecules to market and has many years of experience in multiple molecule classes such as monoclonal antibodies, recombinant proteins, interferons, enzymes, fusion molecules ...

The Swiss Vaccine Sector Brief

  • Industry report
  • April 2010
  • 19 pages

... As vaccines, successful in clinical phase ii. Direct technological competitor to redbiotec 16business summary redbiotec. Medicago, ligocyte, selectvaccines vaccine companies with different approaches to vlp ...

The Swiss Biopharmaceutical Industry Analysis

  • Industry report
  • February 2009
  • 84 pages

... Be manipulated to produce highly specific versions of a given antibody that have a better circulatory half-life, targeted tissue distribution and/or increased potency than the originals. Moreover, the yeast ...

Protein Business (protein, biopharmaceutical, recombinant protein) in Netherlands and Switzerland

  • Industry report
  • June 2008
  • 3 pages

... To produce protein products effectively, where the industry has struggled to date with low yields and unstable platforms. This record surpasses all other production systems including those previously set ...

Company Report: Biopharmaceutical in Germany, Austria and Switzerland for Year 2012

  • Company report
  • November 2012
  • 3 pages

... Represented by its new brand boehringer ingelheim bioxcellence . As a leading biopharmaceutical contract manufactu with more than 35 years of experience The company has brought 19 biopharmaceutical ...

Search in Biopharmaceutical Industry

» Purchase Premium Reports (From $ 250 - $ 250)

10 reports
Glenmark Pharmaceuticals S.A - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals S.A - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Glenmark Pharmaceuticals S.A (Glenmark Pharma) is a research and development company, based in Switzerland. The company operates through Biotechnology. The discovery and development of novel biological ...

Glenmark Pharmaceuticals S.a - Pharmaceuticals & Health ...

January 2014 $ 250

Global Biobetters Trends Industry

January 2014 $ 950

Global Virus-like Particles (vlps) Trends Industry

January 2014 $ 950

Sports Nutrition Market Analysis In Switzerland

August 2013 $ 898

Actelion Ltd Swot

August 2011 $ 175

Biopharmaceutical In Switzerland: Actelion Ltd

April 2010 $ 175

Ucb: Pipeline - Products ? Performance - Potential

January 2010 $ 1 165

Company Financials: Actelion Ltd

January 2010 $ 75

Actelion Ltd Financial Analysis

April 2009 $ 125

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.